Professor Peter Farr
Professor of Clinical Photobiology
- Weatherhead SC, Farr PM, Reynolds NJ. Spectral effects of UV on psoriasis.
Photochemical & Photobiological Sciences 2013, 12(1), 47-53.
- Weatherhead S, Farr P, Swan D, Jamieson D, Hallinan J, Lloyd J, Wipat A, Reynolds N. Apoptosis of keratinocytes is a key mechanism in UVB-induced clearance of psoriasis.
In: 41st Annual Meeting of the European Society for Dermatological Research. 2011, Barcelona, Spain: Nature Publishing Group.
- Weatherhead SC, Farr PM, Jamieson D, Hallinan JS, Lloyd JL, Wipat A, Reynolds NJ. Keratinocyte Apoptosis in Epidermal Remodeling and Clearance of Psoriasis Induced by UV Radiation.
Journal of Investigative Dermatology 2011, 131(9), 1916-1926.
- Weatherhead S, Farr P, Lloyd J, Reynolds NJ. Keratinocyte apoptosis is an important mechanism in the remodelling of psoriatic plaques by ultraviolet B.
In: British Journal of Dermatology: 91st Annual Meeting of the British Association of the Dermatologists. 2011, London, UK: Wiley-Blackwell Publishing Ltd.
- Weatherhead SC, Farr PM, Swan DC, Reynolds NJ. The differential genetic effects of therapeutic ultraviolet B in psoriatic epidermis.
In: British Journal of Dermatology: 91st Annual Meeting of the British Association of the Dermatologists. 2011, London, UK: Wiley-Blackwell Publishing Ltd.
- Weatherhead SC, Farr PM, Swan DC, Reynolds NJ. The differential genetic effects of therapeutic UVB in psoriatic epidermis.
In: British Journal of Dermatology: Annual Meeting of the British Society for Investigative Dermatology. 2011, Manchester, UK: Wiley-Blackwell Publishing Ltd.
- Weatherhead SC, Farr PM, Reynolds NJ. Proliferative potential and stage of cell cycle determines keratinocyte susceptibility to UV-induced apoptosis.
In: 40th Annual Meeting of the European Society for Dermatological Research. 2010, Helsinki, Finland: Journal of Investigative Dermatology: Nature Publishing Group.
- Das S, Lloyd JJ, Farr PM. Measurement of the minimal phototoxic dose is important for optimal psoralen plus ultraviolet A treatment of psoriasis.
In: British Journal of Dermatology: 83rd Annual Meeting of the British Association of Dermatologists. 2003, Brighton, UK: Wiley-Blackwell Publishing Ltd.
- Taylor DK, Anstey AV, Coleman AJ, Diffey BL, Farr PM, Ferguson J, Ibbotson S, Langmack K, Lloyd JJ, McCann P, Martin CJ, Menage HD, Moseley H, Murphy G, Pye SD, Rhodes LE, Rogers S. Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group workshop.
British Journal of Dermatology 2002, 146(5), 755-763.
- Turner RJ, Walshaw D, Diffey BL, Farr PM. A controlled study of ultraviolet A sunbed treatment of psoriasis.
British Journal of Dermatology 2000, 143(5), 957-963.
- Halpern SM, Anstey AV, Dawe RS, Diffey BL, Farr PM, Ferguson J, Hawk JLM, Ibbotson S, McGregor JM, Murphy GM, Thomas SE, Rhodes LE. Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group.
British Journal of Dermatology 2000, 142(1), 22-31.
- Turner RJ, Sviland L, Charlton F, Farr PM. PUVA-related punctate keratoses of the hands and feet.
Journal of the American Academy of Dermatology 2000, 42(3), 476-479.
- Farr PM. Solar urticaria.
British Journal of Dermatology 2000, 142(1), 4-5.
- Gordon PM, Diffey BL, Matthews JNS, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis.
Journal of the American Academy of Dermatology 1999, 41(5), 728-732.
- Meggitt SJ, Farr PM. Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs.
British Journal of Dermatology 1999, 141(3), 591-592.
- Ibbotson SH, Farr PM. The time-course of psoralen ultraviolet a (PUVA) erythema.
Journal of Investigative Dermatology 1999, 113(3), 346-349.
